作者搜索结果 :: APM

1

Comparative analysis of genes regulated by PML/RARα and PLZF/RARα in response to retinoic acid using oligonucleotide arrays 由 Dorothy J. Park, Peter T. Vuong, Sven de Vos, Dan Douer, H. Phillip Koeffler

出版 2003

获取全文获取全文
Artigo

加到收藏夹

Saved in:
2

Characterization of gene expression of CD34+ cells from normal and myelodysplastic bone marrow 由 Wolf‐K. Hofmann, Sven de Vos, Martina Komor, Dieter Hoelzer, William Wachsman, H. Phillip Koeffler

出版 2002

获取全文获取全文
Artigo

加到收藏夹

Saved in:
3

Primary effusion lymphoma in women: report of two cases of Kaposi's sarcoma herpes virus-associated effusion-based lymphoma in human immunodeficiency virus-negative women 由 Said Jw, Taizo Tasaka, Seisho Takeuchi, Hiroya Asou, Sven de Vos, Ethel Cesarman, DM Knowles, HP Koeffler

出版 1996

获取全文获取全文
Artigo

加到收藏夹

Saved in:
4

Ph+ acute lymphoblastic leukemia resistant to the tyrosine kinase inhibitor STI571 has a unique BCR-ABL gene mutation 由 Wolf‐K. Hofmann, Letetia C. Jones, Nathan A. Lemp, Sven de Vos, Harald Gschaidmeier, Dieter Hoelzer, Oliver G. Ottmann, H. Phillip Koeffler

出版 2002

获取全文获取全文
Artigo

加到收藏夹

Saved in:
5

Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death 由 Mary C. Clark, Mabel Pang, Daniel K. Hsu, Fu‐Tong Liu, Sven de Vos, Randy D. Gascoyne, Jonathan W. Said, Linda G. Baum

出版 2012

获取全文获取全文
Artigo

加到收藏夹

Saved in:
6

$Safety and efficacy of navitoclax, a BCL-2 and BCL-X <sub>L</sub> inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study$

Safety and efficacy of navitoclax, a BCL-2 and BCL-X <sub>L</sub> inhibitor, in patients with relapsed or refractory lymphoid malignancies: results from a phase 2a study 由 Sven de Vos, John P. Leonard, Jonathan W. Friedberg, Jasmine Zain, Kieron Dunleavy, Rod Humerickhouse, John Hayslip, John C. Pesko, Wyndham H. Wilson

出版 2020

获取全文获取全文
Artigo

加到收藏夹

Saved in:
7

Kaposi's sarcoma-associated herpesvirus (KSHV or HHV8) in primary effusion lymphoma: ultrastructural demonstration of herpesvirus in lymphoma cells 由 Walid Bin Mohd Said, K. Chien, Seisho Takeuchi, Taizo Tasaka, Hiroya Asou, Steve K. Cho, Sven de Vos, Ethel Cesarman, DM Knowles, HP Koeffler

出版 1996

获取全文获取全文
Artigo

加到收藏夹

Saved in:
8

Gene Expression Profile of Serial Samples of Transformed B-Cell Lymphomas 由 Sven de Vos, Wolf-Karsten Hofmann, Thomas M. Grogan, Utz Krug, Mathew Schrage, Thomas P. Miller, Jonathan Braun, William Wachsman, H. Phillip Koeffler, Jonathan W. Said

出版 2003

获取全文获取全文
Artigo

加到收藏夹

Saved in:
9

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correl... 由 Eric D. Hsi, Sin‐Ho Jung, Raymond Lai, Jeffrey L. Johnson, James R. Cook, Dan Jones, Sven deVos, Bruce D. Cheson, Lloyd E. Damon, Jonathan W. Said

出版 2008

获取全文
Artigo

加到收藏夹

Saved in:
10

Belinostat in combination with standard cyclophosphamide, doxorubicin, vincristine and prednisone as first-line treatment for patients with newly diagnosed peripheral T-cell lympho... 由 Patrick B. Johnston, Amanda F. Cashen, Petros Nikolinakos, Anne Beaven, Stefan K. Barta, Gajanan Bhat, Steven J. Hasal, Sven de Vos, Yasuhiro Oki, Changchun Deng, Francine M. Foss

出版 2021

获取全文获取全文
Artigo

加到收藏夹

Saved in:
11

Management of adverse events associated with idelalisib treatment: expert panel opinion 由 Steven Coutré, Jacqueline C. Barrientos, Jennifer R. Brown, Sven de Vos, Richard R. Furman, Michael J. Keating, Daniel Li, Susan O’Brien, John M. Pagel, Martin Poleski, Jeff P. Sharman, Nai-Shun Yao, Andrew D. Zelenetz

出版 2015

获取全文
Revisão

加到收藏夹

Saved in:
12

Translocation Products in Acute Myeloid Leukemia Activate the Wnt Signaling Pathway in Hematopoietic Cells 由 Carsten Müller‐Tidow, Björn Steffen, Thomas Cauvet, Lara Tickenbrock, Ping Ji, Sven Diederichs, Bülent Sargin, Gabriele Köhler, Matthias Stelljes, Elena Puccetti, Martin Ruthardt, Sven deVos, Scott W. Hiebert, H. Phillip Koeffler, Wolfgang E. Berdel, Hubert Serve

出版 2004

获取全文
Artigo

加到收藏夹

Saved in:
13

A phase II study of dacetuzumab (SGN-40) in patients with relapsed diffuse large B-cell lymphoma (DLBCL) and correlative analyses of patient-specific factors 由 Sven de Vos, Andres Forero‐Torres, Stephen M. Ansell, Brad S. Kahl, Bruce D. Cheson, Nancy L. Bartlett, Richard R. Furman, Jane N. Winter, Henry G. Kaplan, John M. Timmerman, Nancy Whiting, Jonathan G. Drachman, Ranjana H. Advani

出版 2014

获取全文获取全文
Artigo

加到收藏夹

Saved in:
14

$Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study$

Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study 由 André Goy, Steven H. Bernstein, Brad S. Kahl, Benjamin Djulbegović, Michael J. Robertson, Sven de Vos, Elliot Epner, A. Krishnan, John P. Leonard, Sagar Lonial, Sunita D. Nasta, Owen A. O’Connor, Hongliang Shi, Anthony Boral, Richard I. Fisher

出版 2008

获取全文
Artigo

加到收藏夹

Saved in:
15

$Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma$

Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma 由 Richard I. Fisher, Steven H. Bernstein, Brad S. Kahl, Benjamin Djulbegović, Michael J. Robertson, Sven de Vos, Elliot Epner, Amrita Krishnan, John P. Leonard, Sagar Lonial, Edward A. Stadtmauer, Owen A. O’Connor, Hongliang Shi, Anthony Boral, André Goy

出版 2006

获取全文
Artigo

加到收藏夹

Saved in:
16

The landscape of new drugs in lymphoma 由 Anas Younes, Stephen M. Ansell, Nathan Fowler, Wyndham H. Wilson, Sven de Vos, John F. Seymour, Ranjana H. Advani, Andres Forero, Franck Morschhauser, Marie José Kersten, Kensei Tobinai, Pier Luigi Zinzani, Emanuele Zucca, Jeremy S. Abramson, Julie M. Vose

出版 2016

获取全文
Revisão

加到收藏夹

Saved in:
17

$Multicenter Randomized Phase II Study of Weekly or Twice-Weekly Bortezomib Plus Rituximab in Patients With Relapsed or Refractory Follicular or Marginal-Zone B-Cell Lymphoma$

Multicenter Randomized Phase II Study of Weekly or Twice-Weekly Bortezomib Plus Rituximab in Patients With Relapsed or Refractory Follicular or Marginal-Zone B-Cell Lymphoma 由 Sven de Vos, André Goy, Shaker R. Dakhil, Mansoor N. Saleh, Peter McLaughlin, Robert J. Belt, Christopher R. Flowers, Mark Knapp, Lowell L. Hart, Dipti Patel‐Donnelly, Martha Glenn, Stephanie A. Gregory, Charles Holladay, Tracy Zhang, Anthony Boral

出版 2009

获取全文获取全文
Artigo

加到收藏夹

Saved in:
18

Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in FcγRIIIa-Genotyped Patients with Previously Treated Follicular Lymp... 由 Andres Forero‐Torres, Sven de Vos, Brad Pohlman, Maksim Pashkevich, Damien M. Cronier, Nam H. Dang, Susan P. Carpenter, Barrett W. Allan, James G. Nelson, Christopher A. Slapak, Mitchell R. Smith, Brian K. Link, James E. Wooldridge, Kristen N. Ganjoo

出版 2012

获取全文
Artigo

加到收藏夹

Saved in:
19

$Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma$

Targeting Bruton tyrosine kinase with ibrutinib in relapsed/refractory marginal zone lymphoma 由 Ariela Noy, Sven de Vos, Catherine Thiéblemont, Peter Martin, Christopher R. Flowers, Franck Morschhauser, Graham P. Collins, Shuo Ma, Morton Coleman, Shachar Peles, Stephen D. Smith, Jacqueline C. Barrientos, Alina Smith, Brian Munneke, Isaiah W. Dimery, Darrin M. Beaupre, Robert Chen

出版 2017

获取全文获取全文
Artigo

加到收藏夹

Saved in:
20

Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial 由 Sattva S. Neelapu, Michael Dickinson, Javier Muñoz, Matthew L. Ulrickson, Catherine Thiéblemont, Olalekan O. Oluwole, Alex F. Herrera, Chaitra S. Ujjani, Yi Lin, Peter A. Riedell, Natasha Kekre, Sven de Vos, Christine Lui, Francesca Milletti, Jinghui Dong, Hairong Xu, Julio C. Chávez

出版 2022

获取全文获取全文
Artigo

加到收藏夹

Saved in: